Terms: = Skin cancer AND PDGFRA, MGC74795, 5156, ENSG00000134853, PDGFR2, CD140A, Rhe-PDGFRA, CD140a, P16234 AND Treatment
30 results:
1. Identification of the ageing-related prognostic gene signature, and the associated regulation axis in skin cutaneous melanoma.
Tian C; Liu S; Huo R
Sci Rep; 2023 Jan; 13(1):24. PubMed ID: 36631465
[TBL] [Abstract] [Full Text] [Related]
2. Molecular and immunohistochemical comparison between primary gastrointestinal mucosal melanomas and atypical gastrointestinal stromal tumors.
Song IH; Sung YE; Kang J; Lee A; Lee SH
Pathol Res Pract; 2022 Dec; 240():154189. PubMed ID: 36327823
[TBL] [Abstract] [Full Text] [Related]
3. Diagnosing gastrointestinal stromal tumors: The utility of fine-needle aspiration cytology versus biopsy.
Zhang Y; Renberg S; Papakonstantinou A; Haglund de Flon F
Cancer Med; 2022 Jul; 11(14):2729-2734. PubMed ID: 35301817
[TBL] [Abstract] [Full Text] [Related]
4. Impact of Prior treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma.
Seitter SJ; Sherry RM; Yang JC; Robbins PF; Shindorf ML; Copeland AR; McGowan CT; Epstein M; Shelton TE; Langhan MM; Franco Z; Danforth DN; White DE; Rosenberg SA; Goff SL
Clin Cancer Res; 2021 Oct; 27(19):5289-5298. PubMed ID: 34413159
[TBL] [Abstract] [Full Text] [Related]
5. Hypereosinophilic syndromes - An enigmatic group of disorders with an intriguing clinical spectrum and challenging treatment.
Helbig G; Klion AD
Blood Rev; 2021 Sep; 49():100809. PubMed ID: 33714638
[TBL] [Abstract] [Full Text] [Related]
6. The emerging clinical relevance of genomic profiling in neuroendocrine tumours.
Burak GI; Ozge S; Cem M; Gulgun B; Zeynep DY; Atil B
BMC Cancer; 2021 Mar; 21(1):234. PubMed ID: 33676450
[TBL] [Abstract] [Full Text] [Related]
7. Epidemiology, clinical picture and long-term outcomes of FIP1L1-pdgfra-positive myeloid neoplasm with eosinophilia: Data from 151 patients.
Rohmer J; Couteau-Chardon A; Trichereau J; Panel K; Gesquiere C; Ben Abdelali R; Bidet A; Bladé JS; Cayuela JM; Cony-Makhoul P; Cottin V; Delabesse E; Ebbo M; Fain O; Flandrin P; Galicier L; Godon C; Grardel N; Guffroy A; Hamidou M; Hunault M; Lengline E; Lhomme F; Lhermitte L; Machelart I; Mauvieux L; Mohr C; Mozicconacci MJ; Naguib D; Nicolini FE; Rey J; Rousselot P; Tavitian S; Terriou L; Lefèvre G; Preudhomme C; Kahn JE; Groh M;
Am J Hematol; 2020 Nov; 95(11):1314-1323. PubMed ID: 32720700
[TBL] [Abstract] [Full Text] [Related]
8. Benralizumab for
Kuang FL; Legrand F; Makiya M; Ware J; Wetzler L; Brown T; Magee T; Piligian B; Yoon P; Ellis JH; Sun X; Panch SR; Powers A; Alao H; Kumar S; Quezado M; Yan L; Lee N; Kolbeck R; Newbold P; Goldman M; Fay MP; Khoury P; Maric I; Klion AD
N Engl J Med; 2019 Apr; 380(14):1336-1346. PubMed ID: 30943337
[TBL] [Abstract] [Full Text] [Related]
9. Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease.
Chen GL; Carpenter PA; Broady R; Gregory TK; Johnston LJ; Storer BE; Beumer JH; Qiu J; Cerda K; Le R; Otani JM; Liu H; Ross MA; Arai S; Flowers MED; McCarthy PL; Miklos DB
Biol Blood Marrow Transplant; 2018 Feb; 24(2):373-380. PubMed ID: 29051021
[TBL] [Abstract] [Full Text] [Related]
10. Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.
Koseła-Paterczyk H; Rutkowski P
Expert Rev Anticancer Ther; 2017 Dec; 17(12):1107-1116. PubMed ID: 28988501
[TBL] [Abstract] [Full Text] [Related]
11.
Bai X; Kong Y; Chi Z; Sheng X; Cui C; Wang X; Mao L; Tang B; Li S; Lian B; Yan X; Zhou L; Dai J; Guo J; Si L
Clin Cancer Res; 2017 Oct; 23(20):6120-6127. PubMed ID: 28720667
[No Abstract] [Full Text] [Related]
12. Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview.
Farag S; van der Kolk LE; van Boven HH; van Akkooi ACJ; Beets GL; Wilmink JW; Steeghs N
Fam Cancer; 2018 Apr; 17(2):247-253. PubMed ID: 28710566
[TBL] [Abstract] [Full Text] [Related]
13. A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17.
Yeh CN; Chen MH; Chen YY; Yang CY; Yen CC; Tzen CY; Chen LT; Chen JS
Oncotarget; 2017 Jul; 8(27):44121-44130. PubMed ID: 28487491
[TBL] [Abstract] [Full Text] [Related]
14. The Effect of Phototherapy on cancer Predisposition Genes of Diabetic and Normal Human skin Fibroblasts.
Chotikasemsri P; Tangtrakulwanich B; Sangkhathat S
Biomed Res Int; 2017; 2017():7604861. PubMed ID: 28386563
[TBL] [Abstract] [Full Text] [Related]
15. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.
Veija T; Koljonen V; Bohling T; Kero M; Knuutila S; Sarhadi VK
BMC Cancer; 2017 Mar; 17(1):236. PubMed ID: 28359267
[TBL] [Abstract] [Full Text] [Related]
16. Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy.
Ben-Ami E; Barysauskas CM; von Mehren M; Heinrich MC; Corless CL; Butrynski JE; Morgan JA; Wagner AJ; Choy E; Yap JT; Van den Abbeele AD; Solomon SM; Fletcher JA; Demetri GD; George S
Ann Oncol; 2016 Sep; 27(9):1794-9. PubMed ID: 27371698
[TBL] [Abstract] [Full Text] [Related]
17. [ Spectrum of oncogene mutations is different in melanoma subtypes].
Mazurenko NN; Tsyganova IV; Lushnikova AA; Ponkratova DA; Anurova OA; Cheremushkin EA; Mikhailova IN; Demidov LV
Mol Biol (Mosk); 2015; 49(6):1022-9. PubMed ID: 26710785
[TBL] [Abstract] [Full Text] [Related]
18. Identification of melanoma biomarkers based on network modules by integrating the human signaling network with microarrays.
Huang C; Sheng Y; Jia J; Chen L
J Cancer Res Ther; 2014 Nov; 10 Suppl():C114-24. PubMed ID: 25450268
[TBL] [Abstract] [Full Text] [Related]
19. Large-scale analysis of pdgfra mutations in melanomas and evaluation of their sensitivity to tyrosine kinase inhibitors imatinib and crenolanib.
Dai J; Kong Y; Si L; Chi Z; Cui C; Sheng X; Mao L; Li S; Lian B; Yang R; Liu S; Xu X; Guo J
Clin Cancer Res; 2013 Dec; 19(24):6935-42. PubMed ID: 24132921
[TBL] [Abstract] [Full Text] [Related]
20. Specific analysis of KIT and PDGFR-alpha expression and mutational status in Merkel cell carcinoma.
Swick BL; Srikantha R; Messingham KN
J Cutan Pathol; 2013 Jul; 40(7):623-30. PubMed ID: 23621836
[TBL] [Abstract] [Full Text] [Related]
[Next]
